Table 2.
Comorbidities and Medications Use in Patients with Adequate and Inadequate Preparation Quality.
| All Subjects (n=2163) | Adequate Preparation Quality (n=1207) | Inadequate Preparation Quality (n=956) | p-value | |
|---|---|---|---|---|
| Comorbidities | ||||
| Coronary Artery Disease, n (%) | 428 (20.3%) | 209 (17.8%) | 219 (23.5%) | 0.0015 |
| Congestive Heart Failure, n (%) | 124 (5.9%) | 58 (5.0%) | 66 (7.1%) | 0.0403 |
| Diabetes, n (%) | 638 (30.2%) | 307 (26.0%) | 331 (35.5%) | <0.0001 |
| Hypertension, n (%) | 1403 (65.5%) | 737 (61.7%) | 666 (70.3%) | <0.0001 |
| Dementia, n (%) | 27 (1.3%) | 9 (0.8%) | 18 (1.9%) | 0.0198 |
| Stroke, n (%) | 100 (4.8%) | 48 (4.1%) | 52 (5.6%) | 0.1217 |
| Liver Cirrhosis, n (%) | 53 (2.5%) | 24 (2.1%) | 29 (3.1%) | 0.1247 |
| Number of comorbidities, mean ± SD | 1.0 ± 1.1 | 0.9 ± 1.1 | 1.2 ± 1.2 | <0.0001 |
| Charlson index, mean ± SD | 1.3 ± 1.5 | 1.1 ± 1.4 | 1.5 ± 1.6 | <0.0001 |
| Pertinent Medications | ||||
| Narcotics, n (%) | 556 (25.7%) | 285 (23.6%) | 271 (28.3%) | 0.0132 |
| Calcium Channel Blockers, n (%) | 339 (15.7%) | 170 (14.1%) | 169 (17.7%) | 0.0237 |
| Anticholinergics, n (%) | 428 (19.8%) | 224 (18.6%) | 204 (21.3%) | 0.1151 |
| Iron Supplements, n (%) | 121 (5.6%) | 64 (5.3%) | 57 (6.0%) | 0.5112 |
| Anticonvulsants, n (%) | 69 (3.2%) | 31 (2.6%) | 38 (4.0%) | 0.0839 |
SD, Standard Deviation